We’re checking in with Canadian cannabis producer CannTrust Holdings (TSX:TRST) (NYSE:CTST). A leader in the Canadian medical cannabis market, CannTrust stock is currently selling for $5.31 USD on the NYSE.
Prices are down in recent weeks; the company’s disappointing Q4 results on March 28th caused a sell-off. But the long-term picture for the company could be bright—are we entering buy-in territory here?
CannTrust Stock Offers Buy-In PotentialLet’s recap. Before the March results, the CTST stock price had doubled year-to-date, reaching highs of $10.04 USD. But as stated, the company has since shed all ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.